Neurocrine Biosciences Inc (NBIX.OQ)
NBIX.OQ on NASDAQ Stock Exchange Global Select Market
78.47USD
12:20pm EST
78.47USD
12:20pm EST
Change (% chg)
$-0.89 (-1.12%)
$-0.89 (-1.12%)
Prev Close
$79.36
$79.36
Open
$79.37
$79.37
Day's High
$79.73
$79.73
Day's Low
$77.51
$77.51
Volume
80,081
80,081
Avg. Vol
360,046
360,046
52-wk High
$126.15
$126.15
52-wk Low
$64.73
$64.73
Consensus Recommendations
| Consensus Recommendation | Next Earnings (approx.) | Company Fiscal Year End Month |
Last Updated |
|---|---|---|---|
| Outperform | -0.86 | December | 21 Feb 2019 |
Analyst Recommendations and Revisions
| 1-5 Linear Scale | Current | 1 Month Ago |
2 Month Ago |
3 Month Ago |
|---|---|---|---|---|
| (1) BUY | 6 | 6 | 6 | 5 |
| (2) OUTPERFORM | 7 | 9 | 9 | 8 |
| (3) HOLD | 3 | 1 | 1 | 1 |
| (4) UNDERPERFORM | 0 | 0 | 0 | 0 |
| (5) SELL | 0 | 0 | 0 | 0 |
| No Opinion | 0 | 0 | 0 | 0 |
| Mean Rating | 1.81 | 1.69 | 1.69 | 1.71 |
Consensus Estimates Analysis
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| # of Estimates | Mean | High | Low | 1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Mar-19 | 12 | 136.79 | 143.50 | 127.10 | 122.19 |
| Quarter Ending Jun-19 | 12 | 159.01 | 181.30 | 145.00 | 153.64 |
| Year Ending Dec-19 | 16 | 672.43 | 734.00 | 596.90 | 625.07 |
| Year Ending Dec-20 | 13 | 926.03 | 1,018.90 | 778.60 | 929.12 |
| Earnings (per share) | |||||
| Quarter Ending Mar-19 | 14 | -0.86 | 0.09 | -1.48 | 0.17 |
| Quarter Ending Jun-19 | 14 | 0.09 | 0.73 | -1.29 | 0.46 |
| Year Ending Dec-19 | 16 | -0.10 | 0.84 | -1.06 | 1.75 |
| Year Ending Dec-20 | 13 | 2.69 | 3.78 | 0.61 | 3.88 |
| LT Growth Rate (%) | 1 | 155.00 | 155.00 | 155.00 | -- |
Historical Surprises
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| Estimates vs Actual | Estimate | Actual | Difference | Surprise % |
|---|---|---|---|---|
| SALES (in millions) | ||||
| Quarter Ending Dec-18 | 131.60 | 131.49 | 0.11 | 0.08 |
| Quarter Ending Sep-18 | 147.95 | 151.76 | 3.81 | 2.58 |
| Quarter Ending Jun-18 | 83.78 | 96.90 | 13.12 | 15.66 |
| Quarter Ending Mar-18 | 63.05 | 71.09 | 8.04 | 12.75 |
| Quarter Ending Dec-17 | 87.77 | 94.52 | 6.75 | 7.69 |
| Earnings (per share) | ||||
| Quarter Ending Dec-18 | 0.18 | 0.19 | 0.01 | 4.00 |
| Quarter Ending Sep-18 | 0.46 | 0.52 | 0.06 | 13.66 |
| Quarter Ending Jun-18 | -0.17 | -0.07 | 0.10 | -58.28 |
| Quarter Ending Mar-18 | -0.30 | -0.47 | 0.17 | -55.12 |
| Quarter Ending Dec-17 | 0.18 | 0.07 | 0.11 | 61.43 |
Consensus Estimates Trend
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| Current | 1 Week Ago |
1 Month Ago |
2 Month Ago |
1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Mar-19 | 136.79 | 136.79 | 141.07 | 140.35 | 122.19 |
| Quarter Ending Jun-19 | 159.01 | 159.01 | 153.48 | 151.05 | 153.64 |
| Year Ending Dec-19 | 672.43 | 672.43 | 636.97 | 636.25 | 625.07 |
| Year Ending Dec-20 | 926.03 | 926.03 | 903.44 | 900.30 | 929.12 |
| Earnings (per share) | |||||
| Quarter Ending Mar-19 | -0.86 | -0.86 | 0.20 | 0.20 | 0.17 |
| Quarter Ending Jun-19 | 0.09 | 0.09 | 0.30 | 0.29 | 0.46 |
| Year Ending Dec-19 | -0.10 | -0.10 | 1.61 | 1.59 | 1.75 |
| Year Ending Dec-20 | 2.69 | 2.69 | 3.49 | 3.44 | 3.88 |
Estimates Revisions Summary
| Last Week | Last 4 Weeks | |||
|---|---|---|---|---|
| Number Of Revisions: | Up | Down | Up | Down |
| Revenue | ||||
| Quarter Ending Mar-19 | 0 | 0 | 1 | 5 |
| Quarter Ending Jun-19 | 0 | 0 | 4 | 2 |
| Year Ending Dec-19 | 0 | 0 | 12 | 4 |
| Year Ending Dec-20 | 0 | 0 | 8 | 3 |
| Earnings | ||||
| Quarter Ending Mar-19 | 0 | 0 | 0 | 8 |
| Quarter Ending Jun-19 | 0 | 0 | 1 | 7 |
| Year Ending Dec-19 | 0 | 0 | 0 | 16 |
| Year Ending Dec-20 | 0 | 0 | 1 | 11 |
Earnings vs. 
Estimates